MedPath

湖北午时药业有限公司

Ownership
-
Established
1996-07-26
Employees
-
Market Cap
-
Website
www.wushiyaoye.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

147

NMPA:147

Drug Approvals

Valsartan and Amlodipine Tablets(Ⅰ)

Product Name
缬沙坦氨氯地平片(Ⅰ)
Approval Number
国药准字H20249724
Approval Date
Dec 10, 2024
NMPA

麻仁丸

Approval Number
国药准字Z42020128
Approval Date
Jun 7, 2024
NMPA

肾康宁胶囊

Approval Number
国药准字Z20090850
Approval Date
Mar 18, 2024
NMPA

Voriconazole Capsules

Product Name
伏立康唑胶囊
Approval Number
国药准字H20140139
Approval Date
Mar 18, 2024
NMPA

Compound Zine Gluconate, Ferrous Gluconate and Calcium Gluconate Orel Solution

Product Name
复方锌铁钙口服溶液
Approval Number
国药准字H20090321
Approval Date
Feb 7, 2024
NMPA

珍菊降压片

Approval Number
国药准字Z20093014
Approval Date
Sep 11, 2023
NMPA

龙芪颗粒

Approval Number
国药准字Z20090083
Approval Date
May 12, 2023
NMPA

银黄分散片

Approval Number
国药准字Z20080596
Approval Date
Feb 8, 2023
NMPA

妇月康片

Approval Number
国药准字Z20080559
Approval Date
Jan 17, 2023
NMPA

Meclofenoxate Hydrochloride for Injection

Product Name
注射用盐酸甲氯芬酯
Approval Number
国药准字H20084376
Approval Date
Jan 17, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 15
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.